Johanna Mercke Odeberg (Former)

1 – 6 of 6

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/d9f25622-6f6b-42dc-b926-e4653af053ad?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2008
Mark Drug-induced torsades de pointes: a review of the Swedish pharmacovigilance database.
Aström-Lilja, Cecilia ; Mercke Odeberg, Johanna ^LU ; Ekman, Elisabet and Hägg, Staffan (2008) In Pharmacoepidemiology and Drug Safety 17(6). p.587-592
- Contribution to journal › Article
2006
Mark UGT1A polymorphisms in a Swedish cohort and a human diversity panel, and the relation to bilirubin plasma levels in males and females.
Mercke Odeberg, Johanna ^LU ; Andrade, J ; Holmberg, K ; Höglund, Peter ^LU ; Malmqvist, Ulf ^LU and Odeberg, J (2006) In European Journal of Clinical Pharmacology 62(10). p.829-837
- Contribution to journal › Article
2005
Mark Studies on intrinsic and extrinsic sources of variability in pharmacokinetics and pharmacodynamics
Mercke Odeberg, Johanna ^LU (2005)
- Thesis › Doctoral thesis (compilation)
2004
Mark A pharmacokinetic and pharmacodynamic study of desmopressin: evaluating sex differences and the effect of pre-treatment with piroxicam, and further validation of an indirect response model.
Mercke Odeberg, Johanna ^LU ; Callréus, Torbjörn ; Lundin, Stefan ; Roth, Bodil ^LU and Höglund, Peter ^LU (2004) In Journal of Pharmacy and Pharmacology 56(11). p.1389-1398
- Contribution to journal › Article
2003
Mark Oral bioavailability of the antioxidant astaxanthin in humans is enhanced by incorporation of lipid based formulations.
Mercke Odeberg, Johanna ^LU ; Lignell, Ake ; Pettersson, Annette and Höglund, Peter ^LU (2003) In European Journal of Pharmaceutical Sciences 19(4). p.299-304
- Contribution to journal › Article
Mark Lipid drug delivery and rational formulation design for lipophilic drugs with low oral bioavailability, applied to cyclosporine.
Mercke Odeberg, Johanna ^LU ; Kaufmann, Peter ; Kroon, Karl Gunnar and Höglund, Peter ^LU (2003) In European Journal of Pharmaceutical Sciences 20(4-5). p.375-382
- Contribution to journal › Article